Write in a clean editor, then format for Current Emergency and Hospital Medicine Reports in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Current Emergency and Hospital Medicine Reports is a peer-reviewed journal published by Springer Nature, covering Cardiac Arrest and Resuscitation, Emergency and Acute Care Studies, Heart Failure Treatment and Management.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Current Emergency and Hospital Medicine Reports 12, 45–58 (2023).
Formats any DOI in Current Emergency and Hospital Medicine Reports style. No sign-up. |
| Publishes research in | Cardiac Arrest and Resuscitation Emergency and Acute Care Studies Heart Failure Treatment and Management Venous Thromboembolism Diagnosis and Management Atrial Fibrillation Management and Outcomes |
| ISSN | 2167-4884 |
| Citation impact (2-yr) | 1.17 |
| h-index | 19 |
| i10-index | 38 |
| Total citations | 1,959 |
| Top institutions publishing here | Wayne State University |
| Journal website | link.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Newborn infants experience acute pain with various medical procedures. Evidence demonstrates that controlling pain in the newborn period is beneficial, improving physiologic, behavioral, and hormonal outcomes. Multiple validated scoring systems exist to assess pain in a neonate; however, there is no standardized or universal approach for pain management. Healthcare facilities should establish a neonatal pain…
Anticoagulants remain the primary strategy for the prevention and treatment of thrombosis. Unfractionated heparin, low molecular weight heparin, fondaparinux, and warfarin have been studied and employed extensively with direct thrombin inhibitors typically reserved for patients with complications or those requiring intervention. Novel oral anticoagulants have emerged from clinical development and are expected to replace older…
